Remetinostat (SHP-141) is a hydroxamic acid-based histone deacetylase (HDAC) inhibitor. Remetinostat alleviates Imiquimod (HY-B0180)-induced psoriatic dermatitis. Remetinostat can be used for study of cutaneous T-cell lymphoma[1][2].
Molecular Weight:
323.34
Purity:
98
CAS Number:
[946150-57-8]
Formula:
C16H21NO6
Target:
HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted